Literature DB >> 24588431

Glycaemic variability, infections and mortality in a medical-surgical intensive care unit.

Abele Donati1, Elisa Damiani2, Roberta Domizi2, Laura Botticelli2, Roberta Castagnani2, Vincenzo Gabbanelli2, Simonetta Nataloni2, Andrea Carsetti2, Claudia Scorcella2, Erica Adrario2, Paolo Pelaia2, Jean-Charles Preiser3.   

Abstract

OBJECTIVE: In critically ill patients, glycaemic variability (GV) was reported as a better predictor of mortality than mean blood glucose level (BGL). We compared the ability of different GV indices and mean BGLs to predict mortality and intensive care unit-acquired infections in a population of ICU patients. DESIGN, SETTING AND PARTICIPANTS: Retrospective study on adult ICU patients with ≥ three BGL measurements. GV was assessed by SD, coefficient of variation (CV) and mean amplitude of glycaemic excursion (MAGE), and by one timeweighted index, the glycaemic lability index (GLI), and compared with mean BGL. We studied 2782 patients admitted to the 12-bed medical-surgical ICU of a teaching hospital from January 2004 until December 2010. MAIN OUTCOME MEASURES: Logistic regression analyses were performed to assess the association between GV and ICU mortality and ICU-acquired infections. The areas under receiver operating characteristic curves were calculated to compare the discriminatory ability of GV and mean BGL for infections and mortality.
RESULTS: Mortality was 16.6%, and 30% of patients had at least one infection. Patients with infections or diabetes or who were treated with insulin had a higher mean BGL and GV than other patients. GLI, SD, CV and MAGE were significantly associated with infections and mortality; mean BGL was not. Quartiles of increasing GLI were independently associated with higher mortality and an increased infection rate. Patients in the upper quartile of mean BGL and GLI had the strongest association with infections (odds ratio, 5.044 [95% CI, 1.695-15.007]; P = 0.004).
CONCLUSION: High GV is associated with higher risk of ICUCrit acquired infection and mortality.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24588431

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  11 in total

Review 1.  Management of critically ill patients with type 2 diabetes: The need for personalised therapy.

Authors:  Palash Kar; Karen L Jones; Michael Horowitz; Adam M Deane
Journal:  World J Diabetes       Date:  2015-06-10

Review 2.  Reporting on Glucose Control Metrics in the Intensive Care Unit.

Authors:  Tironi Rafael Machado; Preiser Jean-Charles
Journal:  Eur Endocrinol       Date:  2015-08-19

3.  Maximal Glycemic Difference, the Possible Strongest Glycemic Variability Parameter to Predict Mortality in ICU Patients.

Authors:  Thanaphruet Issarawattana; Rungsun Bhurayanontachai
Journal:  Crit Care Res Pract       Date:  2020-08-24

4.  Untangling glycaemia and mortality in critical care.

Authors:  Vincent Uyttendaele; Jennifer L Dickson; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase
Journal:  Crit Care       Date:  2017-06-24       Impact factor: 9.097

5.  A systematic scoping review on the consequences of stress-related hyperglycaemia.

Authors:  Elena Olariu; Nicholas Pooley; Aurélie Danel; Montserrat Miret; Jean-Charles Preiser
Journal:  PLoS One       Date:  2018-04-06       Impact factor: 3.240

6.  Glycaemic variability is associated with adverse cardiovascular outcomes in patients hospitalised with an acute myocardial infarction.

Authors:  Thora Y Chai; Mark McLean; Vincent W Wong; N Wah Cheung
Journal:  J Clin Transl Endocrinol       Date:  2019-07-29

7.  Glycemic Variability Is Independently Associated With Poor Prognosis in Five Pediatric ICU Centers in Southwest China.

Authors:  Milan Dong; Wenjun Liu; Yetao Luo; Jing Li; Bo Huang; Yingbo Zou; Fuyan Liu; Guoying Zhang; Ju Chen; Jianyu Jiang; Ling Duan; Daoxue Xiong; Hongmin Fu; Kai Yu
Journal:  Front Nutr       Date:  2022-02-23

8.  Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.

Authors:  Alfonso Mesejo; Juan Carlos Montejo-González; Clara Vaquerizo-Alonso; Gabriela Lobo-Tamer; Mercedes Zabarte-Martinez; Jose Ignacio Herrero-Meseguer; Jose Acosta-Escribano; Antonio Blesa-Malpica; Fátima Martinez-Lozano
Journal:  Crit Care       Date:  2015-11-09       Impact factor: 9.097

9.  Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic control.

Authors:  Roosmarijn T M van Hooijdonk; Jan M Binnekade; Lieuwe D J Bos; Janneke Horn; Nicole P Juffermans; Ameen Abu-Hanna; Marcus J Schultz
Journal:  Ann Intensive Care       Date:  2015-11-02       Impact factor: 6.925

10.  Establishment and Validation of GV-SAPS II Scoring System for Non-Diabetic Critically Ill Patients.

Authors:  Wen-Yue Liu; Shi-Gang Lin; Gui-Qi Zhu; Sven Van Poucke; Martin Braddock; Zhongheng Zhang; Zhi Mao; Fei-Xia Shen; Ming-Hua Zheng
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.